A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of a Single Treatment of AGN-214868 in Patients With Postherpetic Neuralgia

Registry ID

EUCTR2012-002240-24

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Allergan Ltd.

Start date

2012-11-19

Last update

2026-08-16

Conditions

• Postherpetic Neuralgia

Summary

To evaluate the safety, tolerability, and efficacy of AGN-214868 compared with placebo in the treatment of postherpetic neuralgia (PHN).

Locations

• , , Poland
• , , Germany
• , , Austria

Related clinical trials

• Y-4 to Treat the Postherpetic Neuralgia
• The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
• Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
• Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia
• Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain.
• The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.

View on source registry